Table of Content

1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Introduction and Overview
1.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Manufacturer
2.2 Manufacturers Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served, Product Types
2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Competitive Situation and Trends
2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Eli Lilly and Co.
3.1.1 Eli Lilly and Co. Company Profile
3.1.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.1.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.1.4 Eli Lilly and Co. Business Overview
3.2 Genentech, Inc
3.2.1 Genentech, Inc Company Profile
3.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.2.3 Genentech, Inc Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.2.4 Genentech, Inc Business Overview
3.3 OSI Pharmaceuticals Inc
3.3.1 OSI Pharmaceuticals Inc Company Profile
3.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.3.3 OSI Pharmaceuticals Inc Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.3.4 OSI Pharmaceuticals Inc Business Overview
3.4 Erbitux
3.4.1 Erbitux Company Profile
3.4.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.4.3 Erbitux Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.4.4 Erbitux Business Overview
3.5 Amgen Inc.
3.5.1 Amgen Inc. Company Profile
3.5.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.5.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.5.4 Amgen Inc. Business Overview
3.6 Tarceva and Vectibix
3.6.1 Tarceva and Vectibix Company Profile
3.6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.6.3 Tarceva and Vectibix Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.6.4 Tarceva and Vectibix Business Overview
3.7 F. Hoffmann-La Roche Ltd.
3.7.1 F. Hoffmann-La Roche Ltd. Company Profile
3.7.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.7.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.7.4 F. Hoffmann-La Roche Ltd. Business Overview
3.8 AstraZeneca Plc
3.8.1 AstraZeneca Plc Company Profile
3.8.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.8.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.8.4 AstraZeneca Plc Business Overview
3.9 Bristol-Myers Squibb
3.9.1 Bristol-Myers Squibb Company Profile
3.9.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.9.3 Bristol-Myers Squibb Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.9.4 Bristol-Myers Squibb Business Overview
3.10 Novartis AG
3.10.1 Novartis AG Company Profile
3.10.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Overview
3.10.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Performance (2019-2024)
3.10.4 Novartis AG Business Overview
4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historical and Forecast Market Analysis by Type
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Type
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast by Type (2024-2030)
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historical and Forecast Market Analysis by Application
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2019-2024)
5.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size & Forecast (2019-2030)
6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends Analysis by Regions
6.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
7.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
8.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
9.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
10.2 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
11.2 Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
13.2 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
14.2 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 Epidermal Growth Factor Receptor (EGFR) Inhibitor Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industrial Chain Analysis
17 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Dynamic Analysis
17.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends Analysis
17.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers Analysis
17.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges Analysis
17.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints Analysis